Fungal infections in HIV/AIDS

Abstract : Fungi are major contributors to the opportunistic infections that affect patients with HIV/AIDS. Systemic infections are mainly with Pneumocystis jirovecii (pneumocystosis), Cryptococcus neoformans (cryptococcosis), Histoplasma capsulatum (histoplasmosis), and Talaromyces (Penicillium) marneffei (talaromycosis). The incidence of systemic fungal infections has decreased in people with HIV in high-income countries because of the widespread availability of antiretroviral drugs and early testing for HIV. However, in many areas with high HIV prevalence, patients present to care with advanced HIV infection and with a low CD4 cell count or represent with persistent low CD4 cell counts because of poor adherence, resistance to antiretroviral drugs, or both. Affordable, rapid point-of-care diagnostic tests (as have been developed for cryptococcosis) are urgently needed for pneumocystosis, talaromycosis, and histoplasmosis. Additionally, antifungal drugs, including amphotericin B, liposomal amphotericin B, and flucytosine, need to be much more widely available. Such measures, together with continued international efforts in education and training in the management of fungal disease, have the potential to improve patient outcomes substantially.
Type de document :
Article dans une revue
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2017, 〈10.1016/S1473-3099(17)30303-1〉
Liste complète des métadonnées

Littérature citée [95 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01574426
Contributeur : Inserm Cic1424 Centre d'Investigation Clinique Antilles Guyane <>
Soumis le : lundi 14 août 2017 - 14:35:06
Dernière modification le : mercredi 5 septembre 2018 - 16:22:07

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

Citation

Andrew Limper, Antoine Adenis, Thuy Le, Thomas Harrison. Fungal infections in HIV/AIDS. The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2017, 〈10.1016/S1473-3099(17)30303-1〉. 〈inserm-01574426〉

Partager

Métriques

Consultations de la notice

84